Craig Baker, MD, FACMG

Craig Baker, MD, FACMG

Director, Department of Genetic Medicine - MMI
Interim Medical Director of MMI
Biochemical Geneticist
Assistant Professor of Pediatrics
402-559-3337 | Email 

VIEW MMI GENETIC MEDICINE SERVICES

Professional Summary

Craig Baker, MD, FACMG, is an assistant professor of pediatrics, a biochemical geneticist and the Director of the Department of Genetic Medicine at the UNMC Munroe-Meyer Institute. Dr. Baker also serves as the interim medical director of the Munroe-Meyer Institute.

Craig, a Nebraska native, joined the MMI Genetic Medicine team in 2020 as his first faculty position. He is board certified in Clinical Genetics and Medical Biochemical Genetics. Craig attended medical school in Omaha at Creighton University School of Medicine, completed combined Pediatrics-Medical Genetics residency at the University of Texas Health Science Center of Houston, and Medical Biochemical Genetics fellowship at Stanford University.

Dr. Baker has a primary clinical interest in patients with inherited metabolic diseases. While clinical care is his primary focus, he has additional interests in teaching and research integrating basic science, genomic data and clinical phenotype.

Specialty Certifications

• Clinical Genetics and Genomics, board certified 2019
• Medical Biochemical Genetics, board certified 2021

Education

• Fellowship, Medical Biochemical Genetics, Stanford University – Stanford, CA, 2020
• Residency, Pediatrics-Medical Genetics, UTHealth Science Center at Houston – Houston, TX, 2019
• MD, Creighton University School of Medicine – Omaha, NE, 2015
• BS, Creighton University – Omaha, NE, 2011

Teaching

• “Biochemical Genetics”, UNMC Human Genetics and Cytogenetics Principles graduate course
• “Mitochondrial Disorders”, UNMC Genetic Counseling program
• “The Metabolite is Right”, Stanford Biochemical Genetics Case Conference

Special/Research Interests and Projects

• Inherited metabolic disorders (IMDs)
• Biomedical informatics
• State newborn screening
• Small molecule therapy

Selected Publications

• Hillman P, Baker C, Hebert L, et al. Identification of novel candidate risk genes for myelomeningocele within the glucose homeostasis/oxidative stress and folate/one-carbon metabolism networks. Mol Genet Genomic Med. 2020;8(11):e1495. doi:10.1002/mgg3.1495
• Hebert L, Hillman P, Baker C, et al. Burden of rare deleterious variants in WNT signaling genes among 511 myelomeningocele patients. PLoS One. 2020;15(9):e0239083. Published 2020 Sep 24. doi:10.1371/journal.pone.0239083
• Rush ET, Baker CV, Rizzo WB. Dolichol kinase deficiency (DOLK-CDG): Two new cases and expansion of phenotype. Am J Med Genet A. 2017;173(9):2428-2434. doi:10.1002/ajmg.a.38287

Professional Affiliations

• Nebraska Newborn Screening Advisory Committee
• Society for Inherited Metabolic Disorders
• American College of Medical Genetics
• American Medical Association
• National Organization for Rare Disorder (NORD), Facilitating Multi-site Research Studies & Clinical Trials Working Group